Clover Biopharmaceuticals

About:

Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing vaccines and biologic therapeutic.

Website: http://www.cloverbiopharma.com/

Twitter/X: CloverBiopharma

Top Investors: Temasek Holdings, OrbiMed, Delos Capital, GL Ventures LLC, Coalition for Epidemic Preparedness Innovations

Description:

Clover Biopharmaceuticals is a global, clinical-stage, research-based biotechnology company focused on discovering, developing and commercializing transformative biologic therapies, with a focus on oncology and autoimmune diseases. Clover is utilizing its proprietary Trimer-Tag© technology platform to develop novel biologics targeting trimerization-dependent pathways. Additionally, Clover is leveraging its in-house cGMP biomanufacturing capabilities to develop select biosimilars.